Norwood Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Norwood Financial's PFE Position: Q1 2024 in Review
Norwood Financial reduced its Pfizer (PFE) stake by 57% in Q1 2024, selling an estimated $293K and leaving 7,843 shares worth $218K. The position accounts for 0.31% of the portfolio, ranked #68.
Norwood Financial first reported a position in PFE in Q4 2021 and has held it in 10 quarters since. The position peaked at $784K in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Norwood Financial held 7,843 shares of Pfizer worth $218K as of Q1 2024.
- Norwood Financial sold 10,573 Pfizer shares in Q1 2024, an estimated $293K.
- Pfizer made up 0.31% of Norwood Financial's portfolio in Q1 2024, its #68 holding.
- Norwood Financial first reported a position in Pfizer in Q4 2021 and has held it in 10 quarters since.
- Norwood Financial's Pfizer position peaked at $784K in Q4 2021.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.